ScholarIQanswers from OpenAlex

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study

PaperCitations, authors & open-access status

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study have?

ScholarIQcitation count

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study has 75 citations in the OpenAlex counts ScholarIQ stores.

When was Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study published?

ScholarIQyear

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study has 2021 year in the ScholarIQ index.

What is the open-access status of Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study?

ScholarIQoa status

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study has bronze oa status in the ScholarIQ index.

What is the DOI of Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study?

ScholarIQdoi

The DOI for Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study is on the source record.

What is the PMID of Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study?

ScholarIQpmid

The PMID for Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study is on the source record.

What is the OpenAlex record for Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study?

ScholarIQopenalex

The OpenAlex for Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial